Subtypes and associated factors of prenatal depressive symptoms and their association with health-related quality of life among pregnant women: a cross-sectional study.

Publication date: Jul 17, 2026

Pregnant women with prenatal depression could have distinctly heterogeneous constellations of symptoms. Classifying prenatal depressive symptoms into different subtypes using a person-centered approach and investigating their associated factors are beneficial for personalized assessment and management of the disorder. However, relevant evidence is still lacking. A cross-sectional study was conducted in the obstetrics outpatient clinics of two university-affiliated, governmental, tertiary hospitals in Xi’an City, Northwestern China. A total of 1020 pregnant women were included in the study and administered with a researcher-designed sociodemographic, health-related and pregnancy-related information sheet, the 8-item Patient Health Questionnaire, the five-level EuroQol five-dimension questionnaire, the Generalized Anxiety Disorder-7 and the Pregnancy Stress Rating Scale. Latent profile analysis was used to classify prenatal depressive symptoms into different subtypes, while a multivariate binomial logistic regression model was employed to identify the associated factors of the different subtypes. Health-related quality of life, prenatal anxiety and stress were compared across subtypes of prenatal depressive symptoms. Prenatal depressive symptoms were classified into three subtypes, including ‘minimal-to-mild symptoms’ (58. 6%), ‘mild-to-moderate psychosomatic symptoms’ (17. 1%) and ‘mild-to-moderate melancholic symptoms’ (24. 3%). Multiple sociodemographic, health-related and pregnancy-related factors were associated with the subtypes of prenatal depressive symptoms. Moreover, health-related quality of life, prenatal anxiety and stress differed significantly across subtypes of prenatal depressive symptoms. Pregnant women with depressive symptoms could be classified into distinct subgroups characterized by heterogeneous clinical manifestations. With further validation, investigating the relevant associated factors may become a useful addition to routine prenatal healthcare, facilitating the identification of women at risk of different subtypes and the implementation of early individualized management.

Open Access PDF

Concepts Keywords
Depressive symptoms
Latent profile analysis
Prenatal

Semantics

Type Source Name
disease MESH included
disease MESH Generalized Anxiety Disorder
disease MESH anxiety
pathway REACTOME Reproduction
drug DRUGBANK Coenzyme M
disease MESH preeclampsia
disease MESH gestational diabetes
disease MESH preterm birth
disease MESH miscarriage
disease MESH stillbirth
disease MESH dysmenorrhea
disease MESH vomiting
disease MESH Mental Disorders
disease MESH pain
disease MESH face
disease MESH plan
disease MESH IBM
disease MESH AIC
disease MESH depressive disorders
drug DRUGBANK Progesterone
drug DRUGBANK Hydrocortisone
disease MESH lethargy
disease MESH fatigue
disease MESH clinical depression
disease MESH anhedonia
disease MESH gynecologic diseases
disease MESH Gan
disease MESH adverse birth outcomes
drug DRUGBANK Carboxyamidotriazole
disease MESH postpartum depression
disease MESH COVID 19 pandemic
disease MESH syndrome
drug DRUGBANK L-Aspartic Acid
drug DRUGBANK Trestolone
disease MESH injuries
disease MESH Park
disease MESH PACT
disease MESH psychosis
disease MESH insomnia
drug DRUGBANK Elm
disease MESH somatic symptoms
drug DRUGBANK Trihexyphenidyl
drug DRUGBANK Profenamine
drug DRUGBANK Zinc
disease MESH Dis
disease MESH image
disease MESH Lam

Original Article

(Visited 6 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *